$
₹
$10.017.26% (+0.67)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
0
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
—
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Company Profile
Peers
Peers
ABBV
P/E Ratio
111.08
111.08
1Y Return
17.94%
17.94%
Buy Reco %
57.14
57.14
AMGN
P/E Ratio
24.68
24.68
1Y Return
19.48%
19.48%
Buy Reco %
46.87
46.87
P/E Ratio
17.08
17.08
1Y Return
15.59%
15.59%
Buy Reco %
63.33
63.33
P/E Ratio
26.38
26.38
1Y Return
0.5%
0.5%
Buy Reco %
52.94
52.94
P/E Ratio
14.94
14.94
1Y Return
17.93%
17.93%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
Financial ServicesCapital Markets
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Hyperliquid Strategies Inc Common Stock | - | 0 | - |
| AbbVie Inc | 111.08 | 50.45 | 0.62 |
| Amgen Inc | 24.68 | 20.86 | 2.34 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Hmm, looks like data is currently unavailable. Once it's updated, you can view it here
